Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 2/20 | 0.55 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.47 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SI | P14410 | 1/20 | 0.47 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GLS | O94925 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19911532 | 0.88 | HCAR3 (0.57) | HCAR3SLC9A1CYP1A2ALDH1A1MGAM | |
| SCHEMBL19911564 | 0.88 | SLC9A1 (0.50) | HCAR3SLC9A1CYP1A2ALDH1A1MGAM | |
| SCHEMBL19911531 | 0.86 | HCAR3 (0.59) | HCAR3SLC9A1CYP1A2ALDH1A1MGAM | |
| SCHEMBL19911537 | 0.85 | ALDH1A1 (0.47) | CYP1A2ALDH1A1MGAMAMY1AGAA | |
| SCHEMBL19911547 | 0.84 | ALDH1A1 (0.44) | HCAR3CYP1A2ALDH1A1MGAMAMY1A | |
| SCHEMBL3474345 | 0.84 | ALDH1A1 (0.44) | HCAR3CYP1A2ALDH1A1MGAMAMY1A | |
| SCHEMBL20986085 | 0.82 | ALDH1A1 (0.46) | HCAR3CYP1A2ALDH1A1MGAMAMY1A | |
| SCHEMBL19911534 | 0.81 | ALDH1A1 (0.44) | CYP1A2ALDH1A1MGAMAMY1AGAA | |
| SCHEMBL19911543 | 0.81 | ALDH1A1 (0.44) | CYP1A2ALDH1A1MGAMAMY1AGAA | |
| SCHEMBL3724968 | 0.80 | TDO2 (0.47) | ALDH1A1MGAMAMY1AGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111465603-B | Triazolopyridines as gamma secretase modulators | 勃林格殷格翰国际有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-11339161-B2 | Triazolo pyridines as modulators of gamma-secretase | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-05-24 | — | — | US | disclosed |
| US-20210017173-A1 | TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2021-01-21 | — | — | US | disclosed |
| EP-3672971-A1 | TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE | Boehringer Ingelheim International GmbH (DE) | 2020-07-01 | — | — | EP | disclosed |
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210017173-A1 | TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE | BACE1, BACE2, APP | HCAR3 3204/4885SLC9A1 4743/4885CYP1A2 1146/4885 |
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | HCAR3 4636/4885SLC9A1 341/4885CYP1A2 2689/4885 |
| US-11339161-B2 | Triazolo pyridines as modulators of gamma-secretase | BACE1, BACE2, APP | HCAR3 3204/4885SLC9A1 4743/4885CYP1A2 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.